Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
McInnes, Iain B Mease, Philip J Kirkham, Bruce Kavanaugh, Arthur Ritchlin, Christopher T Rahman, Proton van der Heijde, Désirée Landewé, Robert Conaghan, Philip G Gottlieb, Alice B Richards, Hanno Pricop, Luminita Ligozio, Gregory Patekar, Manmath Mpofu, Shephard